CPRX
Catalyst Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$31.49
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 17.49x
- PEG TTM
- 0.90x
- Price / book
- 3.81x
- Price / sales
- 6.46x
- Price / cash flow
- 18.51x
Enterprise value
- Enterprise value
- $3.1B
- EV / sales
- 5.20x
- EV / EBITDA
- 9.27x
- EV / EBIT
- 11.59x
- Market cap
- $3.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026